Hepatitis B | HCP and trainees in certain populations at high risk for chronic hepatitis B (eg, those born in countries with high and intermediate endemicity) should be tested for HBsAg and anti-HBc/anti-HBs to determine infection status. |
Influenza | Emphasize that all HCP, not just those with direct patient care duties, should receive an annual influenza vaccination. |
Comprehensive programs to increase vaccine coverage among HCP are needed; influenza vaccination rates among HCP within facilities should be measured and reported regularly. | |
MMR | History of disease is no longer considered adequate presumptive evidence of measles or mumps immunity for HCP; laboratory confirmation of disease was added as acceptable presumptive evidence of immunity. History of disease has never been considered adequate evidence of immunity for rubella. |
The footnotes have been changed regarding the recommendations for personnel born before 1957 in routine and outbreak contexts. Specifically, guidance is provided for 2 doses of MMR for measles and mumps protection and 1 dose of MMR for rubella protection. | |
Pertussis | HCP, regardless of age, should receive a single dose of Tdap as soon as feasible if they have not previously received Tdap. |
The minimal interval was removed, and Tdap now can be administered regardless of interval since the last tetanus- or diphtheria-containing vaccine. | |
Hospitals and ambulatory care facilities should provide Tdap for HCP and use approaches that maximize vaccination rates. | |
Varicella | Criteria for evidence of immunity to varicella were established. For HCP they include: |
Written documentation with 2 doses of vaccine; | |
Laboratory evidence of immunity or laboratory confirmation of disease; | |
Diagnosis of history of varicella disease by health care provider or diagnosis of history of herpes zoster by health care provider. | |
Meningococcal | HCP with anatomic or functional asplenia or persistent complement component deficiencies should now receive a 2-dose series of meningococcal conjugate vaccine. HCP with HIV infection who are vaccinated should also receive a 2-dose series. |
Those HCP who remain in groups at high risk are recommended to be revaccinated every 5 years. |
↵* Updated recommendations made since publication of the 1997 summary of recommendations (CDC Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices [ACIP] and the Hospital Infection Control Practices Advisory Committee [HICPAC]. MMWR 1997;46[No. RR-18]).
↵† Is now “Healthcare.”
CDC, Centers for Disease Control and Prevention; HBsAg, hepatitis B surface antigen; anti-HBc, hepatitis B core antibody; anti-HBs, hepatitis B surface antibody; HCP, health care personnel; MMR, measles, mumps, rubella; Tdap, tetanus toxoid, reduced diptheria toxoid, and acellular pertussis vaccine, adsorbed.
Reprinted with permission from: Centers for Disease Control and Prevention. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(RR-7):1-45.